Concepedia

Iksung Cho

IC

112

Publications

9.2K

Citations

46

H-Index

1998

Active since

Affiliations

Yonsei University(Current)

Novavax (United States)

Yonsei University Health System

Emory University

Gangnam Severance Hospital

Iksung Cho is an author at Yonsei University specializing in medicine, public health, and cardiovascular disease.

ORCID

Top concepts

Publications per year

1998–2024

112

Publications

112

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 652 citations · Full text

Coronary Atherosclerotic Precursors of Acute Coronary Syndromes

Hyuk‐Jae Chang, Fay Y. Lin, Sang‐Eun Lee et al. · Journal of the American College of Cardiology · 2018 · 454 citations · Full text

, , +9

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay et al. · New England Journal of Medicine · 2021 · 445 citations · Full text

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

Robert B. Belshe, William C. Gruber, Paul M. Mendelman et al. · The Journal of Pediatrics · 2000 · 430 citations

, , +7

Rows per page

1–5 of 112